| 1 |
Development of TNAP inhibitor, A new drug for medical treatment Aortic Stenosis |
| Small Molecules |
Aortic stenosis |
TNAP |
Hit |
REDNVIA Inc. |
RS-2023-00217370 |
|
| 2 |
GGT-001, Pulmonary Arterial Hypertension AAV Gene Therapy |
| Gene Therapy |
Pulmonary hypertension |
FGF12 |
Lead |
GluGene Therapeutics |
RS-2023-00217737 |
|
| 3 |
Determining the efficacy and discovery of optimal lead compounds of a novel class of diuretics, pendrin inhibitors, for treatment of congestive heart failure and chronic kidney disease |
| Small Molecules |
Congestive heart failure, Chronic renal disease |
pendrin |
Lead |
Yonsei University |
HN21C0281 |
|
| 4 |
Inhaler development with PDGFR small molecule inhibitors for pulmonary arterial hypertension |
| Small Molecules |
Pulmonary hypertension |
PDGFR |
Candidate |
Voronoi, Inc |
RS-2022-00165937 |
|
| 5 |
Project Cell penetrating miRNA-based therapy for acute myocardial infarction |
| Gene Therapy |
Acute heart failure |
miRNA (miR-A, 128-3p, 34a-5p, B, 203a-3p) |
Candidate |
StemMeditech Inc. |
HN21C0741 |
|
| 6 |
GB107, Gene therapy for ischemic limb disease via new expression vector and PT1 technology |
| Nucleic acid/Virus |
Peripheral arterial disease, Diabetic peripheral neuropathy |
HGF |
Candidate |
G&P Bioscience |
HN21C0644 |
|
